Pakistan ranks fifth globally in the number of tuberculosis (TB) cases and fourth for drug-resistant TB, a concerning ...

Following the success of recent clinical trials, several major infectious disease agencies updated treatment guidance for ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

The 25% reduction in the price of pretomanid could save Global Drug Facility clients upwards of $3 million a year.

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

A new all-oral treatment regimen for patients with drug-resistant tuberculosis has commenced in Papua New Guinea (PNG).

This treatment is given when TB is either resistant to rifampicin, a critical first-line drug, or rifampicin and isoniazid, another first-line drug combination. These resistant strains are ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

India has set an ambitious target to eliminate tuberculosis (TB) by 2025, five years ahead of the global sustainable ...